. We can see from the chart that increasing costs for all prerequisites for personnel and facilities causes a rise in production costs for health examinations. Should we work toward early detection even if production costs rise? If we were to convert the benefit from early detection into money, about how much would it come to? In order to analyze the economic efficacy of early detection we compared medical costs for 4 cases of early stage and 3 cases of advanced stage of lung cancer, the leading cause of death among Japanese.
COMPARISON OF THE COSTS FOR MEDICAL CARE OF LUNG CANCERS, EARLY STAGE VS. ADVANCED STAGE
The chart shows medical costs incurred from operations for the 7 representative cases of lung cancer (3 advanced, 4 early) at a highly specialized medical institution for thoracic surgery in the Kinki region (Table 2) .
Medical costs for the cases early detected were limited to those incurred at the time of surgery, while those for the cases advanced continued for a prolonged time after discharge from the hospital for subsequent visits as well as for repeated hospitalization.
Patients of early detected lung cancer spent an average of 20 days in the hospital for surgery. Their average medical costs during hospitalization were 1,261,700 yen. Patients spent an average of 10 days in follow-up visits to the hospital after surgery.
Patients of advanced lung cancer spent an average of 37 days in the hospital for surgery; medical costs incurred while in the hospital amounted to an average of 2,161,110 yen. Taking just this fac- 
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COMPARISON OF PROSTATE CANCER MEDICAL COSTS BY CANCER STAGE
The disparity between medical costs for early detection cases and late detection cases of prostate cancer is even more dramatic than that for lung cancer. The early stage total prostatectomy case shown to the left of the chart was completely cured after 31 days of hospitalization and 3 trips to the hospital for observation during the year following surgery (Table 5) .
Medical costs comprised 1,050,000 yen for hospital care and 30,000 yen for follow-up visits, for a total of 1,080,000 yen. The advanced prostate cancer case shown to the right of the chart was inoperable. The patient received injection therapy on an outpatient basis at a monthly cost of about 110,000 yen. Medical costs for each year reached 1,270,000 yen. This continued until the patient died of metastasis four years later. The total cost was 5,090,000 yen, some 4.7 times the cost of early detected cancer case.
RAPID INCREASE IN COLON CANCER DETECTION USING THE QUANTITATIVE FECAL OCCULT BLOOD TEST, 3-DAY METHOD
We have also experienced a large increase in detection through using invented method of judgments after comparing immunologi- cal measurements 3 times in colon screening for fecal occult blood (Fig. 5) 
